Tenax Therapeutics (TENX) Cash from Operations (2010 - 2026)
Tenax Therapeutics (TENX) reported Cash from Operations of 9309000.0 for Q1 2026, down 32.99% on a YoY basis from 13891068.0 in Q1 2025, and up 30.53% sequentially from 13400000.0 in Q4 2025.
Tenax Therapeutics (TENX) Cash from Operations (2010 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 17 years of Cash from Operations data on file, last reported at 9309000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 32.99% year-over-year to 9309000.0; the trailing twelve-month figure through Mar 2026 stood at 38109000.0 (down 128.95% YoY), and the FY2025 full-year result was 35800000.0, down 141.71% from the prior year.
- Cash from Operations improved to 9309000.0 in Q1 2026, from 13400000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 922966.0 in Q2 2023 to a low of 13400000.0 in Q4 2025.
- A 5-year average of 4541915.94 and a median of 3330905.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations jumped 73.1% in 2023 and slumped 281.66% in 2025, its largest moves.
- Tracing TENX's Cash from Operations over 5 years: stood at 1688780.0 in 2022, then surged by 30.42% to 1175008.0 in 2023, then slumped by 198.81% to 3511000.0 in 2024, then tumbled by 281.66% to 13400000.0 in 2025, then soared by 30.53% to 9309000.0 in 2026.
- Business Quant data shows TENX's Cash from Operations at 9309000.0 in Q1 2026, 13400000.0 in Q4 2025, and 9170000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | -9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.31 Mn |
| Mar 31, 2026 | -9.31 Mn |
| Dec 31, 2025 | -13.40 Mn |
| Dec 31, 2025 | -13.40 Mn |
| Sep 30, 2025 | -9.17 Mn |
| Sep 30, 2025 | -9.17 Mn |
| Jun 30, 2025 | -6.23 Mn |
| Jun 30, 2025 | -6.23 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Dec 31, 2024 | -3.51 Mn |
| Dec 31, 2024 | -3.51 Mn |
| Sep 30, 2024 | -3.10 Mn |
| Sep 30, 2024 | -3.10 Mn |
| Jun 30, 2024 | -3.03 Mn |
| Jun 30, 2024 | -3.03 Mn |
| Mar 31, 2024 | -5.17 Mn |
| Mar 31, 2024 | -5.17 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Dec 31, 2023 | -1.18 Mn |